Show results for
Refine by
Cancer Marker Suppliers Serving Chad
40 companies found
based inMaryland Heights, MISSOURI (USA)
EastCoast Bio has been a supplier of high quality antigens, antibodies, universal non-mammalian blocking reagents, and specialized immunoassay reagents for the in vitro diagnostic (IVD) manufacturing industry worldwide. Large and small manufacturers ...
based inPoway, CALIFORNIA (USA)
Alfa Scientific Designs, Inc. is a California-licensed, cGMP compliant, and ISO 13485 registered manufacturer of in-vitro diagnostic devices. Founded in 1996, ALFA is a leader in the industry in developing and manufacturing high quality rapid ...
based inEmeryville, CALIFORNIA (USA)
BiosPacific, Inc. was founded in 1989 as a supplier of immunological reagents to the commercial diagnostic industry. Our strength over the years has been to consistently meet the demands of this dynamic industry and our diverse customer base. Over ...
based inDaresbury, UNITED KINGDOM
Point of Care (PoC) medical diagnostics is a $ multi-billion global market. Driven by patient need for self monitoring and healthcare cost savings, hand-held devices or readers offering rapid diagnostic test results are fast replacing often slow and ...
Bio-AMD’s planned Generic PoC Magnetic Immunoassay Detection System (‘MIDS’), is expected to have a significantly enhanced sensitivity based on magnetic nano-particle manipulation and detection, capable of interpreting results on a ...
based inGolestan Town, IRAN
Pishtaz Teb Zaman Diagnostics, started its research, development, and marketing activities in 1998, and rapidly grew to be an international brand specialized in 'In-Vitro Diagnostics Medical Devices and Clinical research'. Our range of products are ...
Carcinoembroyonic antigen (CEA) is a 150300 kD glycoprotein molecule which has been found by Gold and Freedman at 1965 and it is also known as major component of CEA glycoprotein family. This family consists of 36 different glycoproteins with the ...
based inPickering, ONTARIO (CANADA)
BTNX Inc. is a biotechnology company and a world leader in rapid, point-of-care diagnostics. We specialize in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests for laboratories, clinics, hospitals and ...
based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
based inHouston, TEXAS (USA)
Healgen Scientific, a wholly owned subsidiary of Zhejiang Orient Gene Biotech Co.,Ltd, develops, manufactures and commercializes in-vitro diagnostic test systems worldwide. Our product portfolio spans multiple testing categories and analytes to meet ...
The Alpha-Fetoprotein (AFP) Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of AFP in whole blood, serum or plasma to aid in the diagnosis of Hepatocellular Carcinoma or fetal open neural tube defects. ...
based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
Comprehensive health screening, something common in many countries outside of the U.S. has been something that is rarely accessible for most Americans. By placing a high priority on early detection, most cancers can be survivable when detected early ...
based inLublin, POLAND
BioMaxima S.A. is a Polish company listed on GPW Main Market, producer of microbiology media as well as a wide range of reagents and in vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics ...
BioMaxima was the first in Poland to start production of rapid diagnostic tests. The most popular and flagship product is the fecal occult blood test used for the diagnosis of colorectal cancer. We offer tests for infectious ...
based inSanta Clara, CALIFORNIA (USA)
LumiQuick Diagnostics Inc., located in the heart of Silicon Valley, California, USA, develops, manufactures and markets high quality point of care tests and other immunoassay kits for the world-wide In vitro diagnostic market. Through years of ...
LumiQuick QuickProfile Cancer Marker Tests are In vitro immunochromatography based one-step assays that include Fecal Occult Blood, (FOB), Alpha Fetoprotein (AFP), Prostate Specific Antigen (PSA) and ...
based inShanghai, CHINA
Tellgen Corporation was established in 2003 at the Medicine Valley in Shanghai, also known as the Silicon Valley of China, which is the first to develop reagents based on Luminex Platforms. Went public in 2017 in Shenzhen and grew to 1000 employees. ...
The TESMI F4000 System is an autoanalyzer based on flow cytometry. This multiplex system is able to test up to 100 analytes in one sample with a minimum sample size. It can do nucleic acid assays, receptor-ligand assays, immunoassays and enzymatic ...
based inSeoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
Analysis of cancer-related genes through blood. Through a simple blood draw, key genes related to various cancer types of solid cancers (including gastric, lung, colon, breast, liver, pancreatic, ovarian and uterine cancer, as well as rare cancers ...
based inHangzhou City, CHINA
Cnpair Biotech Co., Ltd. is a professional provider which concentrates on IVD core materials, including antibodies and proteins, and we are dedicated to developing and delivering highly competitive antibodies and proteins with outstanding ...
based inPoway, CALIFORNIA (USA)
Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver ...
based inMalvern, PENNSYLVANIA (USA)
A proven pioneer and partner to the diagnostics industry. Fujirebio is an R&D-driven company constantly developing new technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby ...
CanChek Tumor Marker Control Serum is intended for use as an assayed quality control serum to monitor the accuracy of laboratory testing for neuron specific enolase (NSE), S100B protein and squamous cell carcinoma antigen (SCCA). The use of a ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Viewing cancer through the immune lens (immuno-oncology) has led to the most promising advancements in cancer treatment in recent history, nonetheless the full potential of the approach is as yet ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta and Carina Biotech to develop next-generation i-body enabled CAR-T cancer therapeutics. AdAlta has entered a collaboration agreement with Carina Biotech to develop next-generation i-body enabled CAR-T cells, with the potential to bring CAR-T ...
based inMarburg, GERMANY
DRG, founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor, with successful representation in over 110 countries through a network of DRG Subsidiaries and local distributors. The German ...
based inSt. Paul, MINNESOTA (USA)
Carbon Medical Technologies, Inc. (FKA Advanced UroScience, Inc.) was formed in 1994 for the purpose of developing permanent human implantable products utilizing pyrolytic carbon. Carbon is a naturally occurring element in the human body. As a ...
